Last reviewed · How we verify

Eperisone hydrochloride

Eisai Co., Ltd. · Phase 3 active Small molecule

Eperisone hydrochloride is a muscle relaxant that reduces muscle tension by inhibiting monoamine oxidase and enhancing noradrenergic and serotonergic neurotransmission in the central nervous system.

Eperisone hydrochloride is a muscle relaxant that reduces muscle tension by inhibiting monoamine oxidase and enhancing noradrenergic and serotonergic neurotransmission in the central nervous system. Used for Muscle tension and spasticity associated with musculoskeletal disorders, Cervical spondylosis with muscle stiffness, Lower back pain with muscle tension.

At a glance

Generic nameEperisone hydrochloride
SponsorEisai Co., Ltd.
Drug classCentrally-acting muscle relaxant
TargetMonoamine oxidase; noradrenergic and serotonergic pathways
ModalitySmall molecule
Therapeutic areaNeurology / Musculoskeletal
PhasePhase 3

Mechanism of action

Eperisone acts as a centrally-acting muscle relaxant with properties that include monoamine oxidase inhibition and modulation of neurotransmitter levels. It reduces muscle stiffness and spasticity through effects on the spinal cord and brainstem, improving motor function without significant sedation. The drug is used primarily for musculoskeletal conditions characterized by muscle tension and spasticity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results